IDUN Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of human therapeutics to control apoptosis. Its products under Phase 2 and preclinical trials include drugs for liver disease, CNS diseases, inflammation, and cancer, as well as IDN-6556 for the treatment of liver diseases in patients infected with Hepatitis C virus.
|(24 Feb 2005)|
|United States||2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products||edit|
PSEPS ID: 120138